These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 26206869)
1. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival. Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869 [TBL] [Abstract][Full Text] [Related]
2. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profile in the activation of subperitoneal fibroblasts reflects prognosis of patients with colon cancer. Yokota M; Kojima M; Higuchi Y; Nishizawa Y; Kobayashi A; Ito M; Saito N; Ochiai A Int J Cancer; 2016 Mar; 138(6):1422-31. PubMed ID: 26370611 [TBL] [Abstract][Full Text] [Related]
4. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer. Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872 [TBL] [Abstract][Full Text] [Related]
5. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment. Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-driven gene expression is an independent prognostic factor in stage II and III colon cancer patients. Dekervel J; Hompes D; van Malenstein H; Popovic D; Sagaert X; De Moor B; Van Cutsem E; D'Hoore A; Verslype C; van Pelt J Clin Cancer Res; 2014 Apr; 20(8):2159-68. PubMed ID: 24486594 [TBL] [Abstract][Full Text] [Related]
7. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins. Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051 [TBL] [Abstract][Full Text] [Related]
8. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Torres S; Bartolomé RA; Mendes M; Barderas R; Fernandez-Aceñero MJ; Peláez-García A; Peña C; Lopez-Lucendo M; Villar-Vázquez R; de Herreros AG; Bonilla F; Casal JI Clin Cancer Res; 2013 Nov; 19(21):6006-19. PubMed ID: 24025712 [TBL] [Abstract][Full Text] [Related]
9. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813 [TBL] [Abstract][Full Text] [Related]
10. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis. Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992 [TBL] [Abstract][Full Text] [Related]
11. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer. Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145 [TBL] [Abstract][Full Text] [Related]
12. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics. Mu Y; Chen Y; Zhang G; Zhan X; Li Y; Liu T; Li G; Li M; Xiao Z; Gong X; Chen Z Electrophoresis; 2013 Jun; 34(11):1679-92. PubMed ID: 23737015 [TBL] [Abstract][Full Text] [Related]
13. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer. Ghosh P; Tie J; Muranyi A; Singh S; Brunhoeber P; Leith K; Bowermaster R; Liao Z; Zhu Y; LaFleur B; Tran B; Desai J; Jones I; Croxford M; Jover R; Goel A; Waring P; Hu S; Teichgraber V; Rohr UP; Ridder R; Shanmugam K; Gibbs P Clin Cancer Res; 2016 Jul; 22(14):3488-98. PubMed ID: 27029492 [TBL] [Abstract][Full Text] [Related]
14. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients. Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer. Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267 [TBL] [Abstract][Full Text] [Related]
17. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling. Barker HE; Bird D; Lang G; Erler JT Mol Cancer Res; 2013 Nov; 11(11):1425-36. PubMed ID: 24008674 [TBL] [Abstract][Full Text] [Related]
18. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Fong SF; Dietzsch E; Fong KS; Hollosi P; Asuncion L; He Q; Parker MI; Csiszar K Genes Chromosomes Cancer; 2007 Jul; 46(7):644-55. PubMed ID: 17394133 [TBL] [Abstract][Full Text] [Related]
19. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation. Doldi V; Callari M; Giannoni E; D'Aiuto F; Maffezzini M; Valdagni R; Chiarugi P; Gandellini P; Zaffaroni N Oncotarget; 2015 Oct; 6(31):31441-60. PubMed ID: 26375444 [TBL] [Abstract][Full Text] [Related]
20. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer. Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]